Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, the first modular mRNA workshop in China, has been delivered
Media
Sep 7, 2021
Walvax
On September 1, 2021, Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, was officially delivered. It is an advanced process combining modular buildings with conventionally built facilities, which allows for tighter construction and can accelerate the industrialization schedule of SARS-CoV-2 mRNA Vaccine. Construction of modular buildings can occur simultaneously with the site and foundation work, allowing projects to be completed in a shorter period.
Related Links
Nov 15, 2024
Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand
Learn More
May 31, 2023
Walvax publishes data on safety, immunogenicity and immune persistence from the Phase 2 trial of its bivalent HPV vaccine Walrinvax™ in Human Vaccines & Immunotherapeutics
Learn More
Apr 14, 2023
Walvax publishes safety and preliminary immunogenicity results from the Phase 1 trial of its bivalent HPV vaccine Walrinvax™ in journal Vaccine
Learn More